RPID has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RPID has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.
As of today, Rapid Micro Biosystems's Total Revenue Growth Rate (Future 3Y To 5Y Est) is 31.14.
For the Medical Devices subindustry, Rapid Micro Biosystems's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:
* The bar in red indicates where Rapid Micro Biosystems's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.
Rapid Micro Biosystems (NAS:RPID) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Thank you for viewing the detailed overview of Rapid Micro Biosystems's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.
Sean M Wirtjes | officer: Chief Financial Officer | C/O VARIAN, INC., 3120 HANSEN WAY, M/S D-083, PALO ALTO CA 94304-1030 |
Spignesi Robert G. Jr. | director, officer: President and CEO | C/O RAPID MICRO BIOSYSTEMS, INC., 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854 |
Kirk Malloy | director | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Kennedy Lewis Capital Partners Master Fund Ii Lp | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Klm Gp Llc | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Capital Partners Master Fund Iii Lp | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Gp Ii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Gp Iii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Investment Holdings Ii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Investment Management Llc | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Management Lp | 10 percent owner | 225 LIBERTY STREET, SUITE 4210, NEW YORK NY 10281 |
David Chene | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Darren Richman | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Inese Lowenstein | director | C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854 |
Richard A Keys | officer: CHIEF COMMERCIAL OFFICER | C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD, SUITE 280, LOWELL MA 01854 |
From GuruFocus
By sperokesalga sperokesalga • 05-05-2023
By PurpleRose PurpleRose • 08-12-2022
By Marketwired • 09-29-2023
By sperokesalga sperokesalga • 02-16-2023
By GuruFocus Research GuruFocus Editor • 05-19-2023
By Value_Insider Value_Insider • 12-01-2022
By sperokesalga sperokesalga • 02-28-2023
By Marketwired • 07-18-2023
By Marketwired • 09-06-2023
By Value_Insider Value_Insider • 12-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.